Key Players and Strategies: Key players in the hydroxychloroquine market include Cipla, Zydus Cadila, Sun Pharmaceutical Industries Ltd., and Sanofi S.A. These companies focus on geographical ...
3don MSN
Given that more than 40% of Indian adults are struggling with obesity and diabetes, affordable weight-loss drugs are expected ...
Several copycat versions of the drug have already been approved, including from Zydus Cadila and Lupin Labs. However, given Astellas’ plan to elevate the case to the Court of Appeals for the ...
He has worked with Zydus Cadila, Cadila Pharma, Panacea Biotech, and Ipca Labs in different capacities. Dr Pratima Srivastava is VP of DMPK at Aragen Life Sciences. She has more than two decades ...
Zydus Lifesciences Ltd. key Products/Revenue Segments include ... As on 30-09-2024, the company has a total of 100.62 Crore shares outstanding.Cadila Healthcare Share Price Today is Rs. 1004.40. On ...
Zydus Healthcare Ltd, one of the country’s leading pharma ... Troikaa Pharmaceuticals Ltd, Cadila Pharmaceuticals Ltd — Rs 5 crore each. Among individuals, Pankaj Kumar Singh (Rs 15 crore), Ramesh ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback